ENDP Endo International plc

+0.17  (+2%)
Previous Close 10.34
Open 10.35
Price To Book -10.72
Market Cap 2357863428
Shares 224,344,760
Volume 1,491,409
Short Ratio
Av. Daily Volume 3,067,501

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Advisory Committee Meeting March 14, 2017 voted 18 to eight that the benefits of reformulated OPANA ER no longer outweigh its risks.
Management of pain
Approved October 26, 2015.
BEMA Buprenorphine
Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate
CRL issued May 30 2013. Approved March 6 2014.
AVEED (testosterone undecanoate) intramuscular injection
Men diagnosed with hypogonadism
BLA filing 2H 2019.
XIAFLEX (collagenase clostridium histolyticum) - RELEASE
Edematous fibrosclerotic panniculopathy (“cellulite”)

Latest News

  1. Paladin Labs Inc. Announces Approval of Envarsus PA™ (tacrolimus prolonged-release tablets) in Canada
  2. Earnings Preview: Endo International (ENDP) Q4 Earnings Expected to Decline
  3. See what the IHS Markit Score report has to say about Endo International PLC.
  4. FDA files motion to delay Endo litigation, again
  5. Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations
  6. Today's Research Reports on Trending Tickers: OPKO Health and Endo International
  7. Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results
  8. Albany region cities sue pharmaceutical companies over opioid epidemic
  9. Government shutdown puts Endo-FDA lawsuit in limbo
  10. Heron Gains on Priority Review Designation for Pain Drug
  11. Options Traders Expect Huge Moves in Endo (ENDP) Stock
  12. Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations
  13. Endo to Participate at J.P. Morgan Healthcare Conference
  14. Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets
  15. Do Hedge Funds Love Endo International plc (ENDP)? Miller Value offer its opinion
  16. Endo International Drops Ahead Of '60 Minutes' Opioid Segment
  17. Endo International plc (ENDP) Investigated For Violations of Federal Securities Laws by Block & Leviton LLP
  18. Endo International shares fall 8 percent on report of 'shocking' data on opioid distribution